EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹3,313 Cr | ₹2,634 Cr | ₹2,196 Cr | ₹1,695 Cr | ₹1,744 Cr |
What is the latest Profit & Loss Account Balance ratio of EMCURE PHARMACEUTICALS ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹3,313 Cr |
| Mar2024 | ₹2,634 Cr |
| Mar2023 | ₹2,196 Cr |
| Mar2022 | ₹1,695 Cr |
| Mar2021 | ₹1,744 Cr |
How is Profit & Loss Account Balance of EMCURE PHARMACEUTICALS Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,313 Cr | 25.78 | |
| Mar2024 | ₹2,634 Cr | 19.92 | |
| Mar2023 | ₹2,196 Cr | 29.56 | |
| Mar2022 | ₹1,695 Cr | -2.79 | |
| Mar2021 | ₹1,744 Cr | - | |
Compare Profit & Loss Account Balance of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹31,667.9 Cr | 4.3% | 16.2% | 80.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 4.3% |
16.2% |
80.9% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses